Yingjian Medical Group posts profit of $180.8m in FY 2023

Its revenue went down by 10.7% year-on-year to $1b in fiscal year 2023.

Hong Kong healthcare group, Yingjian Medical Group Limited, posted a profit attributable to owners of $180.8m, with basic earnings per share of HK$47.6 cents.

The group’s board of directors recommended a final dividend of $16 cents for the fiscal year.

Its overall revenue went down 10.7% to $1b in FY 2023 compared to FY 2022 due to changes in health policies.

The company's gross profit margin slightly grew from approximately 58.8% in fiscal year 2022 to approximately 59.2% in fiscal year 2023.

It seeks to focus on diversifying its services and increasing market share by working with the government and other partners.

It reported steady growth in its specialist medical and dental segments in fiscal year 2023. Patients returned for non-urgent medical needs as the situation improved. 

The medical group also reported that its investment in dental technology and services contributed to the growth of the dental segment.

One of its aims is to expand its eye healthcare services along with the existing ones provided at Healthy Square H2. 

“The Group shall provide its customers a wider range of eye-related procedures, covering Cataract, Vision Correction, and Retinal Diseases,” read the statement.